DERM insider trading
NasdaqCM HealthcareJourney Medical Corp: insider trade history from SEC Form 4 filings.
About Journey Medical Corp
Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also provides Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Emrosi for the treatment of inflammatory lesions of rosacea; Exelderm cream and solution for the treatment of fungal skin infections; and Targadox, an oral doxycycline drug for adjunctive therapy for severe acne, as well as Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. The company was formerly known as Coronado Dermatology, Inc. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.
Company website: journeymedicalcorp.com
DERM insider activity at a glance
FilingIQ tracks 460 insider transactions for DERM in filings since Jun 30, 2015. The most recent transaction is dated Jul 1, 2026.
Across the full history, 17 open-market purchases
and 158 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on DERM insider trades is 57.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest DERM Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Top insiders trading DERM
Frequently asked
- How many insider trades does FilingIQ track for DERM?
- FilingIQ tracks 460 Form 4 insider transactions for DERM (Journey Medical Corp), covering filings from Jun 30, 2015 onwards. 0 of those are dated within the last 90 days.
- Are DERM insiders net buyers or net sellers?
- Across the full Form 4 history for DERM, 17 transactions (4%) were open-market purchases and 158 (34%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does DERM insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is DERM in?
- Journey Medical Corp (DERM) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $171.27M.
Methodology & sources
Every DERM insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.